Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate

Thursday, April 30, 2020

Catalent Inc the leading global provider of advanced delivery technologies development and manufacturing solutions for drugs biologics cell and gene therapies and consumer health products announced a collaboration with the Janssen Pharmaceutical Comp...

Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19

Thursday, April 30, 2020

Atreca Inc BeiGene Ltd and IGM Biosciences Inc Nasdaq IGMS today announced their plans to collaborate to help address the COVID pandemic The companies will leverage their combined technology and expertise in an effort to discover develop and manufact...

BioDuro & neoX Partner to Create Next Generation Antibody Discovery Platform

Wednesday, April 29, 2020

BioDuro LLC a leading drug discovery and development services organization and neoX a leadingedge artificial intelligence and biophysics focused biotech announced today a strategic cooperation to establish the first antibody discovery platform to com...

Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer

Wednesday, April 29, 2020

QEarth Inc announced that its whollyowned subsidiary QSAM Therapeutics Inc QSAM has signed a Patent and Technology License Agreement and Trademark Assignment with IGL Pharma Inc IGL

M8 Pharmaceuticals and Gennisium Pharma announce an exclusive License and Distribution Agreement of an orphan hybrid drug

Wednesday, April 29, 2020

The US Pharmaceutical Company m Pharmaceuticals and the French Corporation Gennisium Pharma jointly announced that they have entered into an exclusive agreement under which m has the exclusive rights to register and commercialize a more suitable form...

JCR Pharmaceuticals announces Completion of Acquisition of ArmaGen, Inc.

Tuesday, April 28, 2020

JCR Pharmaceuticals Co Ltd announced that it has completed the previously announced acquisition of ArmaGen Inc a privately held US biopharmaceutical company headquartered in San Diego California ArmaGen

Applied BioMath, LLC Announces Collaboration with Xilio Therapeutics

Tuesday, April 28, 2020

Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development today announced a collaboration with Xilio Therapeutics Applied BioMath...

Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer

Monday, April 27, 2020

Sutro Biopharma Inc a clinicalstage drug discovery development and manufacturing company focused on the application of precise protein engineering and rational design to create nextgeneration oncology therapeutics today announced updated interim data...

Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D

Monday, April 27, 2020

Tiziana Life Sciences plc a biotechnology company focused on innovative therapeutics for inflammatory autoimmune and infectious diseases announced today that it pursuant to an asset purchase agreement it has acquired all of the intellectual property...

Hansoh Pharma and NiKang Therapeutics Enter into a Development and Commercialization Partnership for a Novel Treatment for Anti-Viral Diseases in China

Friday, April 24, 2020

Hansoh Pharmaceutical Group Company Limited Hansoh Pharma a leading biopharmaceutical company in China and NiKang Therapeutics Inc NiKang a USbased early stage biotech company focused on discovering and developing innovative small molecule medicines...

Latest Issue
Get instant
access to our latest e-book